Overview
What is Cancer Genomics Consortium?
The Cancer Genomics Consortium is a nonprofit organization situated in Lafayette, Louisiana. Their primary mission is to foster communication and cooperation among cancer cytogenomics laboratories, serving both research and diagnostic purposes. They achieve this goal through various means, including education and collaboration. The organization hosts an annual conference, attended by researchers, students, and the general public, to share knowledge and insights about cancer microarrays and their role in diagnosing, predicting, and treating cancer. The 2022 conference attracted approximately 458 attendees. The Cancer Genomics Consortium's activities contribute to the broader understanding and treatment of cancer, benefiting the medical community and patients alike.
Official website here: www.cancergenomics.org
What are the reviews and ratings of this charity?
Charity Navigator Rating: 91% (Four-Star out of Four Stars)
The Cancer Genomics Consortium has received a strong rating of 91% from Charity Navigator, indicating high performance in terms of accountability and financial health. The organization maintains a robust Program Expense Ratio of 84.23%, demonstrating effective allocation of resources towards its programs. The board is comprised entirely of independent members, which enhances governance and transparency within the organization.
Strengths noted include a perfect score of 100 in both Culture & Community and Feedback Collection categories, showcasing the organization's commitment to community engagement and responsiveness to stakeholder input. Furthermore, there are no indications of material diversion of assets, underscoring the integrity of their financial practices. The presence of essential policies, such as a conflict of interest policy, reflects a structured approach to governance.
However, it is worth mentioning that the organization lacks a whistleblower policy, which is a crucial component of organizational accountability. Despite this minor limitation, the overall assessment indicates that the Cancer Genomics Consortium operates with a high level of integrity and commitment to its mission.
This AI summary has been generated from information found on Charity Navigator.
Is Cancer Genomics Consortium legitimate?
Cancer Genomics Consortium is a legitimate nonprofit organization registered as a 501(c)(3) entity. Cancer Genomics Consortium submitted a form 990, which is a tax form used by tax-exempt organizations in the U.S., indicating its operational transparency and adherence to regulatory requirements. Donations to this organization are tax deductible.
Heare are some key statistics you may want to consider:
Executive Compensation: $0
Professional Fundraising Fees: $0
Other Salaries and Wages: $0
For more financial information, click here
Official website here: www.cancergenomics.org
What is the mission statement of Cancer Genomics Consortium?
The Cancer Genomics Consortium's mission is centered around fostering cooperation among cancer cytogenomics laboratories. This collaboration is aimed at serving research, educational, and diagnostic purposes. The consortium organizes an annual conference, acting as a significant educational event for researchers, students, and the general public. The conference features keynote speakers, invited speakers, and presentations of submitted abstracts from members, attracting a substantial audience, such as the 458 attendees in 2022, to explore the utility of cancer microarrays in diagnosis, prognosis, and therapy for cancer.
Official website here: www.cancergenomics.org
What is the revenue of Cancer Genomics Consortium?
Cancer Genomics Consortium's revenue in 2023 was $441,040.
Official website here: www.cancergenomics.org
Who are the executives of Cancer Genomics Consortium and what are their salaries?
There 120 volunteers at Cancer Genomics Consortium.
Here are 13 key members and their salaries:
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
- Compensation: $0
- Related: $0
- Other: $0
Official website here: www.cancergenomics.org
Where can I find the form 990 for Cancer Genomics Consortium?
Cancer Genomics Consortium's most recent form 990 was submitted in 2023 and can be accessed here.
Official website here: www.cancergenomics.org
Learn more at the official website: www.cancergenomics.org
Mission Statement of Cancer Genomics Consortium
The Cancer Genomics Consortium is dedicated to fostering cooperation and communication among laboratories specializing in cancer cytogenomics. This nonprofit organization's primary goal is to facilitate research, educational, and diagnostic endeavors within this field. By promoting collaboration, the Cancer Genomics Consortium aims to advance the understanding and treatment of cancer, leveraging the collective expertise and resources of its member laboratories.
One of the key activities of the Cancer Genomics Consortium is hosting an annual conference. This event serves as a significant educational platform, attracting researchers, students, and the general public. The conference features keynote speakers, invited presenters, and abstracts submitted by members, offering attendees an opportunity to learn about the latest developments in cancer microarrays and their applications in diagnosis, prognosis, and therapy. The 2022 meeting, for instance, drew approximately 458 participants eager to delve into these topics.
Shop smarter and support your favorite cause with the Give Freely browser extension. Save money with coupons and donate to charity with a single click. Download now!
Impact
July, 2024
The Cancer Genomics Consortium has significantly impacted the field of medical research by promoting communication and collaboration among cancer cytogenomics laboratories. By organizing an annual conference that serves as a primary educational event for researchers, students, and the general public, the consortium facilitates the sharing of cutting-edge advancements in cancer microarrays and their application in diagnosis, prognosis, and therapy for cancer. With approximately 458 attendees at the 2022 meeting, the consortium is actively contributing to advancements in cancer genomics and fostering a supportive community for professionals in the field.
This information is meant to be a general summary of Cancer Genomics Consortium. Please take the time to review official sources before making any decisions based upon the content provided here.
Financials
This financial information is from Propublica.
Other financial information:
This information is from the most recently submitted tax form from this organization, which was in 2023.
- Investment Income: $23,884
- Program Service Revenue: $410,722
- Gross Receipts: $441,040
Assets and Liabilities:
- Total Assets: $534,562
- Total Liabilities: $22,519
- Net Assets: $512,043
Want to help this charity, for free? You can click here to learn more about Give Freely
Programs
Programs are reported by nonprofits in their tax forms and are normally their tax-exempt activities.
ANNUAL MGT SUPPORT
Revenue
$211,000
ANNUAL MGT REGISTRATION
Revenue
$146,533
MEMBERSHIP DUES
Revenue
$53,189
Organization Details
Founding Year
2010
Principal Officer
Xinjie Xu Phd
Website
www.cancergenomics.orgNTEE Category
Code: H12 - Medical research
If you are a representative of Cancer Genomics Consortium and wish to learn more about how Give Freely can help you raise funds, please click here: https://givefreely.com/nonprofits/. Our services are offered at no cost to your organization.